Surgical Treatment of Breast Cancer in BRCA-Mutation Carriers.
作者信息
Özmen Vahit
机构信息
Department of General Surgery, İstanbul University İstanbul Medical Faculty, İstanbul, Turkey.
出版信息
J Breast Health. 2015 Jul 1;11(3):101-105. doi: 10.5152/tjbh.2015.0001. eCollection 2015 Jul.
Abstract
摘要
相似文献
1
Surgical Treatment of Breast Cancer in BRCA-Mutation Carriers.
J Breast Health. 2015 Jul 1;11(3):101-105. doi: 10.5152/tjbh.2015.0001. eCollection 2015 Jul.
2
Breast cancer treatment in mutation carriers: surgical treatment.
Minerva Ginecol. 2016 Oct;68(5):548-56. Epub 2016 Jan 28.
3
Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Ann Ital Chir. 2019;90:1-2.
4
Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer.
World J Surg. 2018 May;42(5):1384-1390. doi: 10.1007/s00268-017-4342-7.
5
Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.
Ann Surg Oncol. 2016 Oct;23(10):3232-8. doi: 10.1245/s10434-016-5328-7. Epub 2016 Jun 23.
6
Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.
Breast Cancer Res Treat. 2014 Apr;144(3):443-55. doi: 10.1007/s10549-014-2890-1. Epub 2014 Feb 25.
7
Preoperative genetic testing affects surgical decision making in breast cancer patients.
Gynecol Oncol. 2014 Aug;134(2):326-30. doi: 10.1016/j.ygyno.2014.05.028. Epub 2014 Jun 5.
8
Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?
Gynecol Oncol. 2017 May;145(2):346-351. doi: 10.1016/j.ygyno.2017.02.032. Epub 2017 Mar 14.
9
Differences between screen-detected and interval breast cancers among BRCA mutation carriers.
Breast Cancer Res Treat. 2019 May;175(1):141-148. doi: 10.1007/s10549-018-05123-6. Epub 2019 Jan 23.
10
Association of Mutations and Anti-müllerian Hormone Level in Young Breast Cancer Patients.
Front Endocrinol (Lausanne). 2019 Apr 11;10:235. doi: 10.3389/fendo.2019.00235. eCollection 2019.
引用本文的文献
1
Management of patients with BRCA mutation from the point of view of a breast surgeon.
Ann Med Surg (Lond). 2021 Apr 16;65:102311. doi: 10.1016/j.amsu.2021.102311. eCollection 2021 May.
本文引用的文献
1
Impact of Prophylactic Mastectomy in BRCA1/2 Mutation Carriers.
Breast Care (Basel). 2014 Dec;9(6):385-9. doi: 10.1159/000369592.
2
The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.
Breast Cancer Res. 2014 Sep 19;16(5):442. doi: 10.1186/s13058-014-0442-6.
3
Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis.
Ann Surg. 2014 Dec;260(6):1000-10. doi: 10.1097/SLA.0000000000000769.
4
Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.
Int J Cancer. 2015 Feb 1;136(3):668-77. doi: 10.1002/ijc.29032. Epub 2014 Jul 8.
5
Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis.
Breast Cancer Res Treat. 2014 Apr;144(3):443-55. doi: 10.1007/s10549-014-2890-1. Epub 2014 Feb 25.
6
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
J Natl Cancer Inst. 2013 Jun 5;105(11):812-22. doi: 10.1093/jnci/djt095. Epub 2013 Apr 29.
7
Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat. 2011 May;127(1):287-96. doi: 10.1007/s10549-010-1336-7. Epub 2011 Jan 9.
8
Prophylactic mastectomy for the prevention of breast cancer.
Cochrane Database Syst Rev. 2010 Nov 10(11):CD002748. doi: 10.1002/14651858.CD002748.pub3.
9
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.
Breast Cancer Res Treat. 2010 Jun;121(2):389-98. doi: 10.1007/s10549-010-0894-z. Epub 2010 Apr 22.
10
Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature.
Breast Cancer Res Treat. 2010 Feb;120(1):119-26. doi: 10.1007/s10549-009-0685-6. Epub 2009 Dec 24.
Zotero 插件